483
ENDO USA, Inc.FDA 483 - ENDO USA, Inc. - August 31, 2010
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of JHP Pharmaceuticals, LLC in Rochester, MI, revealed significant deficiencies in equipment cleaning, design, and quality control procedures. Inspectors found drug product residues on HEPA filters and supply air outlets due to inadequate cleaning intervals and equipment design flaws. The quality control unit also lacked proper written procedures for handling product spills and managing room hold statuses, indicating a breakdown in GMP compliance.
Open in Dashboard
ID · d670c0c9-7a93-4508-a39b-e5bdb8059c15